CD8A and neoplasm: Cisplatin normalized the tumor blood vessels, leading to increased infiltration of CD8+ T cells and upregulation of T cell activation markers IFN-γ and CXCR3, when combined with dual CTLA-4 and PD-1 blockade [178].